← Leaderboards
Luis Solorio
University Of Michigan At Ann Arbor
$3,311,435
Attributed
$4,571,684
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,571,684 · 6
By mechanism
R01$2,247,944 · 2
U01$1,108,513 · 1
R00$697,271 · 1
R21$420,489 · 1
K99$97,467 · 1
Top collaborators
- David John Cappelleri3 shared
- Craig J. Goergen3 shared
- Michael Keith Wendt2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Joseph L Bull$4,492,950
- Xudong Fan$6,206,272
- Edward T Zellers$1,095,578
- Paul L Carson$12,306,224
- Karen F. Stein$6,006,944
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignMalignant NeoplasmsTissuesCellsPropertyCessation Of LifeComplexResponseTumorPreventFlow CytometryEventExtracellular Matrix ProteinsFibroblastsExtracellular MatrixMalignant Neoplasm Of PancreasImplantDistantArchitectureEnvironmentEngineeringCancer CellInvadedCues
Grant awards (13)
Stromal targeting to improve the efficacy of systemically administered drugs for pancreatic ductal adenocarcinomas$605,990
R01 · FY2025 · CA · contact PI
Engineering the Premetastatic Niche$521,240
R01 · FY2025 · CA · contact PI
Stromal targeting to improve the efficacy of systemically administered drugs for pancreatic ductal adenocarcinomas$599,474
R01 · FY2024 · CA · contact PI
Engineering the Premetastatic Niche$521,240
R01 · FY2024 · CA · contact PI
NRI: Mobile Microrobots for Precision Medicine$369,053
U01 · FY2024 · TR
NRI: Mobile Microrobots for Precision Medicine$369,730
U01 · FY2023 · TR
NRI: Mobile Microrobots for Precision Medicine$369,730
U01 · FY2022 · TR
Prescription Opioid Formulation to Deter Extraction, Injection, Insufflation, and Smoking$193,750
R21 · FY2020 · DA · contact PI
Engineering the Cancer Microenvironment$249,000
R00 · FY2019 · CA · contact PI
Prescription Opioid Formulation to Deter Extraction, Injection, Insufflation, and Smoking$226,739
R21 · FY2019 · DA · contact PI
Engineering the Cancer Microenvironment$199,271
R00 · FY2018 · CA · contact PI
Engineering the Cancer Microenvironment$249,000
R00 · FY2017 · CA · contact PI
Engineering the Cancer Microenvironment$97,467
K99 · FY2016 · CA · contact PI